Intra-arterial Substance P Mediated Vasodilatation in the Human Forearm: Pharmacology, Reproducibility and Tolerability
Overview
Affiliations
Aims: The current studies were designed to characterize the pharmacology, reproducibility and tolerability of the vasodilator response to intra-arterial substance P infusion in the forearm of healthy man.
Methods: On different occasions, eight healthy male volunteers received brachial artery infusions of substance P at doubling doses ranging from 0.5 to 128 pmol min(-1). Blood flow was measured in both arms using venous occlusion plethysmography.
Results: Substance P induced dose-dependent vasodilatation in the human forearm which had a log-linear relationship to dose. At doses of 1-8 pmol min(-1), mean responses were highly reproducible both within and between days. There were no differences between responses to discontinuous doses and continuous doses of substance P. Substance P was generally well tolerated at doses of < or = 64 pmol min(-1) with no significant alteration in arterial blood pressure or heart rate. Skin oedema in the infused forearm and systemic vasodilatation, manifested by facial flushing and non-infused forearm vasodilatation, occurred at doses of > or = 16 pmol min(-1).
Conclusions: Forearm vasodilatation to substance P represents a reproducible and useful model in the assessment of peripheral endothelial cell NK1 receptor function.
Cameron A, McMahon K, Hall M, Neves K, Rios F, Montezano A JACC CardioOncol. 2020; 2(3):443-455.
PMID: 33043304 PMC: 7539369. DOI: 10.1016/j.jaccao.2020.06.004.
Rupniak N, Katofiasc M, Marson L, Ricca D, Thor K, Burgard E Neuropeptides. 2019; 77:101956.
PMID: 31324387 PMC: 6739136. DOI: 10.1016/j.npep.2019.101956.
Rupniak N, Katofiasc M, Marson L, Thor K Naunyn Schmiedebergs Arch Pharmacol. 2017; 391(3):299-308.
PMID: 29279967 DOI: 10.1007/s00210-017-1458-0.
Cardiovascular effects of urocortin 2 and urocortin 3 in patients with chronic heart failure.
Stirrat C, Venkatasubramanian S, Pawade T, Mitchell A, Shah A, Lang N Br J Clin Pharmacol. 2016; 82(4):974-82.
PMID: 27275843 PMC: 5026060. DOI: 10.1111/bcp.13033.
Rotigaptide protects the myocardium and arterial vasculature from ischaemia reperfusion injury.
Pedersen C, Venkatasubramanian S, Vase H, Hyldebrandt J, Contractor H, Schmidt M Br J Clin Pharmacol. 2016; 81(6):1037-45.
PMID: 26750458 PMC: 4876181. DOI: 10.1111/bcp.12882.